Phase 1a/1b Study of a Novel BTK Inhibitor, DTRMWXHS-12, and Combination Products, CTRM-505 and DTRM-555, in Patients with Chronic Lymphocytic Leukemia or Other B-Cell Lymphomas
Clinical Trial Grant
Awarded By
Zhejiang DTRM Biopharma Co.Ltd.
Start Date
February 28, 2018
End Date
April 30, 2023
Awarded By
Zhejiang DTRM Biopharma Co.Ltd.
Start Date
February 28, 2018
End Date
April 30, 2023